US FDA’s Biosimilars Group Will Conduct Some Supplement Reviews, Become ‘Like Another Discipline’

 
• By Derrick Gingery
  
division of labor
Signatory authority will remain with the review division, but OTBB staff will perform a primary review of some biosimilar labeling supplements. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics